{
    "paper_id": "PMC4832832",
    "metadata": {
        "title": "Design, Synthesis, and Antiviral Activity of Novel Ribonucleosides of 1,2,3\u2010Triazolylbenzyl\u2010aminophosphonates",
        "authors": [
            {
                "first": "Abdelaaziz",
                "middle": [],
                "last": "Ouahrouch",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Moha",
                "middle": [],
                "last": "Taourirte",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Dominique",
                "middle": [],
                "last": "Schols",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Robert",
                "middle": [],
                "last": "Snoeck",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Graciela",
                "middle": [],
                "last": "Andrei",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Joachim",
                "middle": [
                    "W."
                ],
                "last": "Engels",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Hassan",
                "middle": [
                    "B."
                ],
                "last": "Lazrek",
                "suffix": "",
                "email": null,
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "Currently, most of the human beings in the world suffer from different kinds of diseases caused by DNA and RNA viruses. These diseases are mostly diagnosed but difficult to cure. Vaccination is a reliable tool to fight viral diseases, but it is only available against few viruses. The difficulties associated with national or worldwide vaccination programs make antiviral chemotherapy an even more practical approach in the fight against epidemic viral infections. Nucleoside analogs are synthetic compounds that are structurally similar to natural nucleosides and can serve as building blocks of DNA and RNA. They can act as competitive inhibitors of viral and cellular DNA and RNA polymerases or alternatively can be incorporated into growing DNA and RNA strands causing chain termination 1.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "\u03b1\u2010Aminophosphonates are defined as structural analogs of natural amino acids. They are considered as an important class of compounds with diverse and interesting biological activities. Some of the aminophosphonates were described as anticancer agents 2, enzyme inhibitors 3, peptide mimetics 4, antibiotics and pharmacological agents 5. They have also been reported to be interesting carriers for the transport of hydrophilic molecules across bilayer lipid membranes 6. The \u03b1\u2010aminophosphonate derivatives are often synthesized via the Kabachnik\u2013Fields reaction by coupling of a carbonyl compound, an amine, and a hydroxyphosphoryl compound using various catalysts 7, 8, 9.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "1,2,3\u2010Triazoles were prepared by Huisgen in the 1960s 10 using the 1,3\u2010dipolar cycloaddition reaction with acetylenes. After approximately four decades, this reaction has acquired considerable attention owing to the introduction of copper(I) as catalyst by Medal and then by Sharpless 11, 12, 13. The copper\u2010catalyzed cycloaddition of azides and alkynes (CuAAC) also known as \u201cclick chemistry\u201d offers a simple access to the 1,4\u2010isomer in very short reaction times.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Further, nucleosides containing 1,2,3\u2010triazole ring have been of special interest in drug development research. Some synthetic triazoles have displayed interesting biological activities and several analogs have been tested against hepatitis C and HIV\u20101 viruses 14, 15, 16, 17, 18. Moreover, nucleoside and acyclonucleoside analogs containing 1,2,3\u2010triazole and phosphonate structures have been described as potent antiviral agents 19, 20, 21.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Herein, we describe the synthesis of novel hybrid molecules containing triazolyl\u2010nucleoside linked to \u03b1\u2010aminophosphonates by a phenyl ring. The choice of these structures is based on the combination of both pharmacophore parts, the phenyl\u2010triazolyl\u2010riboside and the \u03b1\u2010aminophosphonates, which are known to have significant pharmacological properties. Our synthesis strategy is based on the use of two reactions: Kabachnick\u2013Fields reaction and 1,3\u2010dipolar cycloaddition. The compounds obtained were tested against selected DNA and RNA viruses.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "The synthesis of the desired compounds (4a\u2013j and 5a\u2013j) is depicted in Scheme 1. Initially, the \u03b1\u2010aminophosphonate compounds were prepared in good yields via the Kabachnik\u2013Fields reaction. The 4\u2010[(trimethylsilyl)ethynyl]benzaldehyde 1 was reacted with diethylphosphite and corresponding amine in acetonitrile using molecular iodine as catalyst 22, 23, 24. The latter is low\u2010priced, readily available, non\u2010metallic, and non\u2010toxic. The mixture was stirred at room temperature for 1 h to get compounds 2a\u2013j. The next step is deprotection of the trimethylsilyl group. For this purpose, tetrabutylammonium fluoride (TBAF) in tetrahydrofurane (THF) was used to give the terminal alkyne 25. The structures of 2e, 2f, 3d, and 3g were confirmed by X\u2010ray diffraction (Fig. 1). According to the crystal data, the structures are similar for these compounds. The P\u2014C bond has a staggered conformation, with the two six\u2010membered groups with respect to the P=O double bond. The two benzene rings are almost perpendicular in all four compounds. In each crystal structure (2e, 3d, and 3g), the molecules are arranged as centrosymmetric or pseudocentrosymmetric dimers related by two N\u2014H\u22efO=P hydrogen bonds. On the other hand, in the crystal structure of 2f, the hydrogen bond N\u2014H\u22efO=P is not found, and the molecules are arranged as centrosymmetric dimers linked by Cmethyl\u2014H\u22efO=P hydrogen bonds 26.",
            "cite_spans": [],
            "section": "Chemistry ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 77,
                    "end": 78,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                },
                {
                    "start": 762,
                    "end": 763,
                    "mention": "1",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Next, the 1,2,3\u2010triazolyl\u2010nucleosides were prepared using the 1,3\u2010dipolar cycloaddition reaction. For this, the terminal alkynes 3a\u2013j and \u03b2\u2010azido\u2010ribose 27 were coupled using the Cu alkyne\u2010azide cycloaddition in basic medium (triethylamine) and the reaction was carried out under microwave irradiation 28. Microwave heating has been shown to increase reaction yields and to speed up reaction time 29, \u03b2\u2010azido\u2010ribose is slightly unstable under micro\u2010wave conditions and was used in excess. The configuration at the anomeric carbon C1\u2032 is retained as it is present in the \u03b2\u2010azido\u2010ribose. The hydroxyl functions were protected by benzoyl groups prior to the CuAAC reaction in order to increase the solubility of the compounds. The structures of all compounds were confirmed on the basis of 1H, 13C NMR spectra as well as by high\u2010resolution mass spectrometry. In the 1H NMR spectra of the intermediates, the triazole proton appears as a singlet in the aromatic region while the anomeric proton appears as a multiplet around 6 ppm.",
            "cite_spans": [],
            "section": "Chemistry ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "The last step involves the removal of the benzoyl protecting groups from O2\u2032, O3\u2032, and O5\u2032 positions of D\u2010ribose 4a\u2013j using sodium methoxide (NaOMe) in methanol 30 to afford the desired 1,2,3\u2010triazole nucleosides 5a\u2013j (Table 1).",
            "cite_spans": [],
            "section": "Chemistry ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "The antiviral activities of the synthesized compounds (4a\u2013j, 5a\u2013j) were tested against different viruses: HIV\u20101 and HIV\u20102 in MT4 cell cultures; herpes simplex virus\u20101 (HSV\u20101) (Kos strain), herpes simplex virus\u20102 (HSV\u20102) (G strain), HSV\u20101 thymidine kinase deficient, acyclovir\u2010resistant (TK\u2212 Kos, ACVr), vaccinia virus, vesicular stomatitis virus (VSV), adenovirus\u20102, varicella\u2010zoster virus (VZV) (Oka strain and TK\u2212 07/1 strain), human cytomegalovirus (HCMV) (AD\u2010169 and Davis strain) in human embryonic lung (HEL) cells; VSV, Coxsackie virus B4, and respiratory syncytial virus (RSV) in HeLa cells; parainfluenza\u20103 virus, reovirus\u20101, Sindbis virus, Coxsackie virus B4, and Punta Toro virus in Vero cells; feline corona virus (FIPV) and feline herpes virus in Crandell\u2010Rees Feline Kidney (CRFK) cells, influenza A H1N1 subtype, influenza A H3N2 subtype, and influenza B virus in MDCK (Madin\u2013Darby canine kidney) cells. The following reference compounds were included: tenofovir (PMPA), AMD3100, ganciclovir, cidofovir, acyclovir, brivudin, the lectins Hippeastrum hybrid agglutinin (HHA) and Urtica dioica agglutinin (UDA), dextran sulfate (molecular weight 10000, DS\u201010000), ribavirin, oseltamivir carboxylate, amantadine and rimantadine, zalcitabine and alovudine. The antiviral activity was expressed as the EC50: the compound concentration required to reduce virus\u2010induced cytopathogenicity or viral plaque formation by 50%. The cytotoxicity of the tested compounds toward the uninfected host cells was defined as the minimum cytotoxic concentration (MCC) that causes a microscopically detectable alteration of normal cell morphology. The 50% cytotoxic concentration (CC50), causing a 50% decrease in cell viability was determined using a colorimetric 3\u2010(4,5\u2010dimethylthiazol\u20102\u2010yl)\u20105\u2010(3\u2010carboxymethoxyphenyl)\u20102\u2010(4\u2010sulfophenyl)\u20102H\u2010tetrazolium (MTS) assay system.",
            "cite_spans": [],
            "section": "Biological testing ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "The tested compounds (4a\u2013j, 5a\u2013j) displayed no antiviral activity against the different viruses tested except for compounds 4b and 4c that showed a slight inhibition of respiratory syncytial virus replication (Table 2) and compounds 5c, 5f, and 5g that displayed weak activity against both TK+ and TK\u2212 VZV strains (see Supporting Information). Although compound 4h had some activity against Coxsackie virus B4 in Vero cell cultures, no activity was seen in HeLa cells (Tables 2 and 3).",
            "cite_spans": [],
            "section": "Biological testing ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "A series of novel 1,2,3\u2010triazolyl ribosides linked to \u03b1\u2010aminophosphonates (4a\u2013j, 5a\u2013j) were successfully prepared in high yield via the Kabachnik\u2013Fields reaction and a Cu(I)\u2010catalyzed alkyne\u2010azide cycloaddition under microwave irradiation. The synthesized compounds were evaluated against a broad range of DNA and RNA viruses, some of them showing modest activity against respiratory syncytial virus (compounds 4b and 4c) and varicella\u2010zoster virus (compounds 5c, 5f, and 5g).",
            "cite_spans": [],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "Reactions were carried out in a microwave oven model AVM510/WP/WH. Reactions were monitored by thin layer chromatography (TLC) on precoated silica gel 60 F254 (Merck, Darmstadt, Germany); UV light was used for visualization of the spots. All products were purified by column chromatography on silica gel (100\u2013200 mesh; Merck). 1H NMR and 13C NMR spectra were recorded on a Bruker 300 and 75 MHz spectrometer, respectively, SiMe4 was used as internal standard. Chemical shifts are given in ppm and coupling constants (J) in MHz and multiplicity is reported as s (singlet), d (doublet), t (triplet), q (quartet), and m (multiplet). Mass spectra were produced by ESI/MS and MALDI\u2010TOF\u2010MS.",
            "cite_spans": [],
            "section": "General ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The compounds 2a\u2013j were synthesized by reaction of commercial (Sigma\u2013Aldrich) 4\u2010[(trimethylsilyl)ethynyl]benzaldehyde 1 (1 mmol), diethylphosphite (1.2 equiv.), and corresponding amine (1.2 equiv.) in acetonitrile (3 mL) using molecular iodine (0.2 equiv.) as catalyst at room temperature, the reaction mixture was stirred at room temperature for 1 h. Then, the solvent was removed under reduced pressure. The resulting residue was purified by column chromatography using ethyl acetate/hexane as eluent.",
            "cite_spans": [],
            "section": "General procedure for the synthesis of diethyl [(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl)(aryl or alkylamino)methyl]phosphonates 2a\u2013j\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 95%; Rf: 0.40; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.22 (s, 9H, \u2014CH3), 1.06 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.20 (t, 3H, \u2014CH3, J = 6.9 Hz), 3.60\u20133.68 (m, 1H, \u2014OCH2\u2014), 3.83\u20133.92 (m, 1H, \u2014OCH2\u2014), 3.97\u20134.08 (m, 2H, \u2014OCH2\u2014), 4.62 (d, 1H, CHP, J = 23.7 Hz), 5.17 (s, 1H, NH), 6.47 (d, 2H, Ar\u2014H, J = 8.1 Hz), 6.61 (t, 1H, Ar\u2014H, J = 7.2 Hz), 7.01 (t, 2H, Ar\u2014H, J = 7.8 Hz), 7.33\u2013738 (m, 4H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.06 (Si\u2014CH3), 16.32\u201316.58 (CH3), 55.20 (CHP), 63.43\u201363.52 (CH2), 94.74, 104.86 (\u2261C\u2014), 114.01, 118.69, 127.84, 129.28, 132.26 (phenyl\u2014CH), 122.81, 136.76, 146.35 (phenyl\u2014C). ESI\u2010MS (M+H), m/z calcd. for C22H30NO3PSi: 415.54, found: 417.00; HRMS (M+K): calcd. for C22H30NO3PSiK: 454.13642, found: 454.13539.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl)(phenylamino)methyl]phosphonate 2a\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 90%; Rf: 0.45; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.10 (s, 9H, \u2014CH3), 1.02 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.10 (t, 3H, \u2014CH3, J = 6.9 Hz), 3.56 (m, 1H, \u2014OCH2\u2014), 3.81 (m, 1H, \u2014OCH2\u2014), 3.95 (m, 2H, \u2014OCH2\u2014), 4.54 (d, 1H, CHP, J = 24.3 Hz), 5.14 (br s, 1H, NH), 6.15 (d, 1H, Ar\u2014H, J = 7.8 Hz), 6.63 (t, 1H, Ar\u2014H, J = 7.2 Hz), 6.71 (t, 2H, Ar\u2014H, J = 7.5 Hz), 6.93\u20137.19 (m, 4H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.00 (Si\u2014CH3), 16.07\u201316.50 (CH3), 54.99 (CHP), 63.15\u201363.68 (CH2), 94.83, 104.76 (\u2261C\u2014), 112.73, 117.82, 118.78, 122.42, 127.06, 127.70, 129.39, 132.46 (phenyl\u2014CH), 122.96 (C\u2014Cl), 120.08, 136.06, 142.29 (phenyl\u2014C). ESI\u2010MS (M+H), m/z calcd. for C22H29ClNO3PSi: 449.98, found: 451.00; HRMS (M+K): calcd. for C22H29ClNO3PSiK: 488.09744, found: 488.09631.",
            "cite_spans": [],
            "section": "Diethyl [2\u2010chlorophenylamino][(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl]methylphosphonate 2b\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 89%; Rf: 0.45; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.10 (s, 9H, \u2014CH3), 0.99 (t, 3H, \u2014CH3, J = 7.2 Hz), 1.07 (t, 3H, \u2014CH3, J = 7.2 Hz), 3.57 (m, 1H, \u2014OCH2\u2014), 3.76 (m, 1H, \u2014OCH2\u2014), 3.91 (m, 2H, \u2014OCH2\u2014), 4.54 (d, 1H, CHP, J = 24.6 Hz), 5.21 (br s, 1H, NH), 6.12 (d, 1H, Ar\u2014H, J = 8.1 Hz), 6.63 (t, 1H, Ar\u2014H, J = 7.5 Hz), 6.71 (t, 2H, Ar\u2014H, J = 7.5 Hz), 7.15\u20137.29 (m, 4H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.00 (Si\u2014CH3), 16.30\u201316.52 (CH3), 55.20 (CHP), 63.43\u201363.72 (CH2), 94.83, 104.76 (\u2261C\u2014), 110.57 (C\u2014Br), 112.77, 119.27, 127.60, 128.36, 132.46\u2013132.52 (phenyl\u2014CH), 122.87, 135.91, 143.07 (phenyl\u2014C). ESI\u2010MS (M+H), m/z calcd. for C22H29BrNO3PSi: 494.43, found: 496.00; HRMS (M+Na): calcd. for C22H29BrNO3PSiNa: 516.07299, found: 516.07122.",
            "cite_spans": [],
            "section": "Diethyl [2\u2010bromophenylamino][(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl]methylphosphonate 2c\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 92%; Rf: 0.40; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.02 (s, 9H, \u2014CH3), 0.92 (t, 3H, \u2014CH3, J = 6.3 Hz), 1.02 (t, 3H, \u2014CH3, J = 6.3 Hz), 3.49 (m, 1H, \u2014OCH2\u2014), 3.71 (m, 1H, \u2014OCH2\u2014), 3.88 (m, 2H, \u2014OCH2\u2014), 4.42 (d, 1H, CHP, J = 24.3 Hz), 4.65 (br s, 1H, NH), 6.17 (d, 2H, Ar\u2014H, J = 9.0 Hz), 6.93 (d, 2H, Ar\u2014H, J = 8.7 Hz), 7.12 (d, 2H, Ar\u2014H, J = 8.1 Hz), 7.19 (d, 2H, Ar\u2014H, J = 8.1 Hz). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.00 (Si\u2014CH3), 16.28\u201316.53 (CH3), 55.15 (CHP), 63.44\u201363.67 (CH2), 94.98, 104.62 (\u2261C\u2014), 110.49 (C\u2014Br), 115.58, 127.70, 131.98\u2013132.36 (phenyl\u2014CH), 122.95, 136.02, 145.11 (phenyl\u2014C). ESI\u2010MS (M+H), m/z calcd. for C22H29BrNO3PSi: 494.43, found: 494.90; HRMS (M+Na): calcd. for C22H29BrNO3PSiNa: 516.07299, found: 516.07251.",
            "cite_spans": [],
            "section": "Diethyl [4\u2010bromophenylamino][(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl]methylphosphonate 2d\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 77%; Rf: 0.36; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.01 (s, 9H, \u2014CH3), 0.91 (t, 3H, \u2014CH3, J = 6.7 Hz), 1.07 (t, 3H, \u2014CH3, J = 6.7 Hz), 3.44 (m, 1H, \u2014OCH2\u2014), 3.74 (m, 1H, \u2014OCH2\u2014), 3.87 (m, 2H, \u2014OCH2\u2014), 4.44 (d, 1H, CHP, J = 24.3 Hz), 5.20 (br s, 1H, NH), 6.25 (d, 2H, Ar\u2014H, J = 6.6 Hz), 6.55 (d, 2H, Ar\u2014H, J = 6.6 Hz), 7.15\u20137.22 (m, 4H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.00 (Si\u2014CH3), 16.25\u201316.51 (CH3), 55.73 (CHP), 63.55\u201363.64 (CH2), 94.87, 104.70 (\u2261C\u2014), 114.95\u2013115.84, 127.82, 132.31 (phenyl\u2014CH), 122.87, 136.32, 142.58 (phenyl\u2014C), 154.84 (C\u2014F). ESI\u2010MS (M+H), m/z calcd. for C22H29FNO3PSi: 433.53, found: 434.80; HRMS (M+K): calcd. for C22H29FNO3PSiK: 472.12699, found: 472.12658.",
            "cite_spans": [],
            "section": "Diethyl [4\u2010fluorophenylamino][(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl]methylphosphonate 2e\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 87%; Rf: 0.43; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.01 (s, 9H, \u2014CH3), 0.89 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.02 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.99 (s, 3H, Ar\u2014CH3), 3.48 (m, 1H, \u2014OCH2\u2014), 3.72 (m, 1H, \u2014OCH2\u2014), 3.86 (m, 2H, \u2014OCH2\u2014), 4.43 (d, 1H, CHP, J = 24.6 Hz), 4.54 (s, 1H, NH), 6.00 (d, 1H, Ar\u2014H, J = 8.4 Hz), 6.93 (d, 1H, Ar\u2014H, J = 8.4 Hz), 6.76 (s, 1H, Ar\u2014H), 7.14\u20137.22 (m, 4H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.00 (Si\u2014CH3), 16.26\u201316.51, 17.38 (CH3), 55.26 (CHP), 63.40\u201363.53 (CH2), 94.81, 104.74 (\u2261C\u2014), 124.81 (C\u2014Cl), 112.56, 126.58, 127.59, 129.96\u2013132.28 (phenyl\u2014CH), 122.90, 136.27, 142.92 (phenyl\u2014C). ESI\u2010MS (M+H), m/z calcd. for C23H31ClNO3PSi: 464.01, found: 465.10; HRMS (M+K): calcd. for C23H31ClNO3PSiK: 502,11309, found: 502.11199.",
            "cite_spans": [],
            "section": "Diethyl [4\u2010chloro\u20102\u2010methylphenylamino][(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl]methylphosphonate 2f\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 88%; Rf: 0.50; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.26 (s, 9H, \u2014CH3), 1.18 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.31 (t, 3H, \u2014CH3, J = 6.9 Hz), 3.78 (m, 1H, \u2014OCH2\u2014), 4.01 (m, 1H, \u2014OCH2\u2014), 4.15 (m, 2H, \u2014OCH2\u2014), 4.94 (d, 1H, CHP, J = 24.3 Hz), 6.10 (br s, 1H, NH), 6.69 (s, 1H, Ar\u2014H), 6.61 (d, 1H, Ar\u2014H, J = 7.2 Hz), 7.20\u20137.74 (m, 9H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.00 (Si\u2014CH3), 16.13\u201316.52 (CH3), 55.09 (CHP), 63.00\u201363.64 (CH2), 94.77, 104.80 (\u2261C\u2014), 106.48, 118.16, 122.80, 126.12, 127.69\u2013132.30 (phenyl\u2014CH), 123.97, 126.85, 134.74, 136.43, 143.99 (phenyl\u2014C). ESI\u2010MS (M+H), m/z calcd. for C26H32NO3PSi: 465.60, found: 467.20; HRMS (M+Na): calcd. for C26H32NO3PSiNa: 488.17813, found: 488.17658.",
            "cite_spans": [],
            "section": "Diethyl (4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl)(2\u2010naphthalenylamino)methylphosphonate 2g\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 78%; Rf: 0.50; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.70 (s, 9H, \u2014CH3), 0.97 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.10 (t, 3H, \u2014CH3, J = 6.9 Hz), 2.27 (br s, 1H, NH), 3.31 (d, 1H, CHP, J = 24.5 Hz), 3.64 (m, 2H, \u2014CH2\u2014NH\u2014), 3.78\u20133.98 (m, 4H, \u2014OCH2\u2014), 7.04\u20137.13 (m, 5H, Ar\u2014H), 7.20 (d, 2H, Ar\u2014H, J = 8.1 Hz), 7.33 (d, 2H, Ar\u2014H, J = 8.1 Hz). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.06 (Si\u2014CH3), 16.25\u201316.48 (CH3), 51.08 (CH2\u2014N), 58.40 (CHP), 61.75\u201363.10 (CH2), 94.54, 104.87 (\u2261C\u2014), 127.22, 128.33\u2013132.08 (phenyl\u2014CH), 122.65, 136.42\u2013139.10 (phenyl\u2014C). ESI\u2010MS (M+H), m/z calcd. for C23H32NO3PSi: 429.56, found: 431.00; HRMS (M+H): calcd. for C23H32NO3PSi: 430.19618, found: 430.19647.",
            "cite_spans": [],
            "section": "Diethyl (benzylamino)(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl)methylphosphonate 2h\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 88%; Rf: 0.40; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.07 (s, 9H, \u2014CH3), 0.63 (m, 6H, \u2014OCH2CH3, \u2014CH3), 0.87\u20131.24 (m, 23H, \u2014CH2\u2014, \u2014OCH2CH3), 2.25 (m, 2H, \u2014CH2\u2014NH\u2014), 3.18 (br s, 1H, NH), 3.68\u20133.93 (m, 4H, \u2014OCH2\u2014), 5.26 (d, 1H, CHP, J = 23.4 Hz), 7.17 (d, 2H, Ar\u2014H, J = 8.2 Hz), 7.59 (d, 2H, Ar\u2014H, J = 8.2 Hz). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.00 (Si\u2014CH3), 14.00, 16.25\u201316.48 (CH3), 22.50, 27.00, 29.11\u201337.56 (CH2), 59.56 (CHP), 63.09\u201363.25 (CH2), 94.54, 104.87 (\u2261C\u2014), 128.64, 132.05 (phenyl\u2014CH), 123.06, 135.00 (phenyl\u2014C). ESI\u2010MS (M+H), m/z calcd. for C28H50NO3PSi: 507.76, found: 509.40; HRMS (M+H): calcd. for C28H50NO3PSi: 508.33703, found: 508.33659.",
            "cite_spans": [],
            "section": "Diethyl (dodecylamino)(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl)methylphosphonate 2i\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 86%; Rf: 0.40; Eluent: ethyl acetate/hexane, 7:3 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.25 (t, 9H, \u2014CH3), 0.86 (m, 6H, \u2014OCH2CH3, \u2014CH3), 1.05\u20131.70 (m, 35H, \u2014CH2\u2014, \u2014OCH2CH3), 2.53 (m, 2H, \u2014CH2\u2014NH\u2014), 3.43 (br s, 1H, NH), 3.78\u20134.16 (m, 4H, \u2014OCH2\u2014, CHP), 7.36 (d, 2H, Ar\u2014H, J = 8.2 Hz), 7.62 (d, 2H, Ar\u2014H, J = 8.2 Hz). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 0.00 (Si\u2014CH3), 14.19, 16.00\u201316.50 (CH3), 22.74, 26.88\u201327.23, 29.51\u201330.30, 32.06, 29.11\u201337.56 (CH2), 59.50 (CHP), 63.00\u201363.50 (CH2), 94.50, 104.00 (\u2261C\u2014), 128.50, 132.00 (phenyl\u2014CH), 123.00, 135.00 (phenyl\u2014C). ESI\u2010MS (M+H), m/z calcd. for C34H62NO3PSi: 591.92, found: 593.50; HRMS (M+H): calcd. for C34H62NO3PSi: 592.43093, found: 592.42999.",
            "cite_spans": [],
            "section": "Diethyl (octadecylamino)(4\u2010(2\u2010(trimethylsilyl)ethynyl)phenyl)methylphosphonate 2j\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The trimethylsilyl ethynyl phenyl \u03b1\u2010aminophosphonates 2 (0.7 mmol) were reacted with tetrabutylammonium fluoride (1 equiv.) in tetrahydrofurane (2.5 mL). After 30 min of stirring at room temperature, the reaction mixture was purified by silica gel column chromatography to get ethynyl phenyl \u03b1\u2010aminophosphonates (3a\u2013j).",
            "cite_spans": [],
            "section": "General procedure for the synthesis of diethyl [(4\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)(aryl or alkylamino)(phenyl)methyl]phosphonates 4a\u2013j\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The terminal alkyne 3 (0.5 mmol) and \u03b2\u2010azido\u2010ribose (2.5 equiv.) and triethyl amine (1.1 equiv.) were mixed with CuI (0.1 equiv.). The reaction mixture was homogenized in dry acetonitrile (1 mL) and stirred for 5 min. The solvent was evaporated under vacuum. The reaction mixture was then irradiated at the power level 400 W for 2\u20135 min. The residue was purified on silica gel using ethyl acetate/hexane as eluent.",
            "cite_spans": [],
            "section": "General procedure for the synthesis of diethyl [(4\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)(aryl or alkylamino)(phenyl)methyl]phosphonates 4a\u2013j\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 95%; Rf: 0.45; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.11 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.26 (t, 3H, \u2014CH3, J = 6.9 Hz), 3.72 (m, 1H, \u2014OCH2\u2014), 3.95 (m, 1H, \u2014OCH2\u2014), 4.11 (m, 2H, \u2014OCH2\u2014), 4.60 (m, 1H, H5\u2032), 4.77 (d, 1H, CHP, J = 25.2 Hz), 4.85\u20134.91 (m, 1H, H5\u2032,H4\u2032, H3\u2032, NH), 6.16 (m, 1H, H2\u2032), 6.30 (m, 1H, H1\u2032), 6.53\u20136.74 (m, 4H, Ar\u2014H), 7.13 (m, 2H, Ar\u2014H), 7.31\u20137.68 (m, 12H, Ar\u2014H, CH\u2014triazole), 7.89\u20138.08 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 15.54, 15.80 (CH3), 54.30 (CHP), 62.64\u201362.76 (C5\u2032, CH2), 70.87 (C2\u2032), 74.61 (C3\u2032), 80.58 (C4\u2032), 89.73 (C1\u2032), 113.26, 117.87, 125.30, 127.86, 128.52, 129.13, 133.05 (phenyl\u2014CH, triazole\u2014CH), 135.51, 145.66, 147.22 (phenyl\u2014C, triazole\u2014C), 164.37, 164.48, 165.40 (CO). ESI\u2010MS (M+H), m/z calcd. for C45H43N4O10P: 830.82, found: 831.40; HRMS (M+K): calcd. for C45H43N4O10PK: 869.23484, found: 869.23435.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(phenylamino)methyl]phosphonate 4a\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 90%; Rf: 0.45; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.12 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.29 (t, 3H, \u2014CH3, J = 6.9 Hz), 3.70 (m, 1H, \u2014OCH2\u2014), 3.81 (m, 1H, \u2014OCH2\u2014), 3.95\u20134.23 (m, 2H, \u2014OCH2\u2014), 4.61 (m, 1H, H5\u2032), 4.77\u20134.90 (m, 3H, CHP, H5\u2032,H4\u2032), 5.45 (m, 1H, H3\u2032), 5.70 (br s, 1H, NH), 6.17 (m, 1H, H2\u2032), 6.30 (m, 1H, H1\u2032), 6.46\u20136.66 (m, 3H, Ar\u2014H), 6.86\u20136.98 (m, 2H, Ar\u2014H), 7.15\u20137.67 (m, 12H, Ar\u2014H, CH\u2014triazole), 7.88\u20138.05 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.25, 16.48 (CH3), 54.85 (CHP), 63.15\u201363.64 (C5\u2032, CH2), 71.56 (C2\u2032), 75.29 (C3\u2032), 81.21 (C4\u2032), 90.41 (C1\u2032), 112.76, 117.66, 118.67, 122.33, 126.03, 128.18, 128.64, 129.35, 133.73 (phenyl\u2014CH, triazole\u2014CH), 120.09 (C\u2014Cl), 135.56, 142.19, 147.78 (phenyl\u2014C, triazole\u2014C), 165.36, 165.40, 166.47 (CO). ESI\u2010MS (M+H), m/z calcd. for C45H42ClN4O10P: 865.26, found: 865.50; HRMS (M+K): calcd. for C45H42ClN4O10PK: 903.19587, found: 903.19617.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(2\u2010chlorophenylamino)methyl]phosphonate 4b\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 92%; Rf: 0.45; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.09\u20131.25 (t, 6H, \u2014CH3), 3.79 (m, 1H, \u2014OCH2\u2014), 3.92 (m, 1H, \u2014OCH2\u2014), 3.94\u20133.99 (m, 2H, \u2014OCH2\u2014), 4.52 (m, 1H, H5\u2032), 4.67\u20134.82 (m, 4H, CHP, NH, H5\u2032,H4\u2032), 5.45 (m, 1H, H3\u2032), 6.04 (m, 1H, H2\u2032), 6.19 (m, 1H, H1\u2032), 6.33\u20136.66 (m, 3H, Ar\u2014H), 6.94 (m, 2H, Ar\u2014H), 7.19\u20137.46 (m, 12H, Ar\u2014H, CH\u2014triazole), 7.79\u20138.03 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.27, 16.50 (CH3), 55.08 (CHP), 63.43\u201363.69 (C5\u2032, CH2), 71.55 (C2\u2032), 75.24 (C3\u2032), 81.27 (C4\u2032), 90.41 (C1\u2032), 110.59 (C\u2014Br), 112.81, 118.53, 119.16, 126.05, 128.12\u2013129.89, 132.51, 133.50 (phenyl\u2014CH, triazole\u2014CH), 135.52, 143.19\u2013147.83 (phenyl\u2014C, triazole\u2014C), 165.04\u2013166.08 (CO). ESI\u2010MS (M+H), m/z calcd. for C45H42BrN4O10P: 909.71, found: 910.70; HRMS (M+K): calcd. for C45H42BrN4O10PK: 947.14535, found: 947.14589.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(2\u2010bromophenylamino)methyl]phosphonate 4c\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 94%; Rf: 0.45; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.11 (t, 3H, \u2014CH3, J = 6.3 Hz), 1.29 (t, 3H, \u2014CH3, J = 6.3 Hz), 3.69 (m, 1H, \u2014OCH2\u2014), 3.93 (m, 1H, \u2014OCH2\u2014), 4.12 (m, 2H, \u2014OCH2\u2014), 4.59 (m, 1H, H5\u2032), 4.70 (d, 1H, CHP, J = 24.3 Hz), 4.78\u20134.89 (m, 3H, H5\u2032, H4\u2032, H3\u2032), 5.20 (br s, 1H, NH), 6.17 (m, 1H, H2\u2032), 6.31 (m, 1H, H1\u2032), 6.54 (m, 3H, Ar\u2014H), 7.15 (m, 2H, Ar\u2014H), 7.31\u20137.63 (m, 12H, Ar\u2014H, CH\u2014triazole), 7.85\u20138.07 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.21, 16.48 (CH3), 54.85 (CHP), 63.38\u201363.60 (C5\u2032, CH2), 71.59 (C2\u2032), 75.25 (C3\u2032), 81.20 (C4\u2032), 90.41 (C1\u2032), 110.16 (C\u2014Br), 115.56, 118.82, 126.03, 128.27\u2013129.86, 131.87, 133.71 (phenyl\u2014CH, triazole\u2014CH), 135.67, 145.32\u2013147.74 (phenyl\u2014C, triazole\u2014C), 165.04\u2013166.06 (CO). ESI\u2010MS (M+H), m/z calcd. for C45H42BrN4O10P: 909.71, found: 911.30; HRMS (M+Na): calcd. for C45H42BrN4O10PNa: 931.17141, found: 931.17355.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(4\u2010bromophenylamino)methyl]phosphonate 4d\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 75%; Rf: 0.40; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.12 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.30 (t, 3H, \u2014CH3, J = 6.9 Hz), 3.72 (m, 1H, \u2014OCH2\u2014), 3.97 (m, 1H, \u2014OCH2\u2014), 4.13 (m, 2H, \u2014OCH2\u2014), 4.60 (m, 1H, H5\u2032), 4.78\u20134.89 (m, 4H, CHP, H5\u2032, H4\u2032, H3\u2032), 5.15 (br s, 1H, NH), 6.16 (m, 1H, H2\u2032), 6.30 (m, 1H, H1\u2032), 6.54 (m, 3H, Ar\u2014H), 6.82 (m, 2H, Ar\u2014H), 7.32\u20137.67 (m, 12H, Ar\u2014H, CH\u2014triazole), 7.91\u20138.10 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.22\u201316.48 (CH3), 55.60 (CHP), 63.33\u201363.51 (C5\u2032, CH2), 71.59 (C2\u2032), 75.28 (C3\u2032), 81.25 (C4\u2032), 90.42 (C1\u2032), 114.88\u2013115.81, 118.63, 126.03, 128.28\u2013129.88, 133.45, 133.88 (phenyl\u2014CH, triazole\u2014CH), 135.96, 142.46\u2013147.83 (phenyl\u2014C), 154.76 (triazole\u2014C), 157.89 (C\u2014F), 165.06\u2013166.08 (CO). ESI\u2010MS (M+H), m/z calcd. for C45H42FN4O10P: 848.81, found: 849.10; HRMS (M+K): calcd. for C45H42FN4O10PK: 887.22542, found: 887.22670.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(4\u2010fluorophenylamino)methyl]phosphonate 4e\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 89%; Rf: 0.40; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.13 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.29 (t, 3H, \u2014CH3, J = 6.9 Hz), 2.28 (s, 3H, Ar\u2014CH3), 3.75 (m, 1H, \u2014OCH2\u2014), 3.98 (m, 1H, \u2014OCH2\u2014), 4.15 (m, 2H, \u2014OCH2\u2014), 4.59 (m, 1H, H5\u2032), 4.63\u20134.90 (m, 4H, CHP, H5\u2032, H4\u2032, H3\u2032), 5.10 (br s, 1H, NH), 6.17 (m, 1H, H2\u2032), 6.30 (m, 2H, Ar\u2014H), 6.54 (m, 1H, H1\u2032), 6.91 (d, 1H, Ar\u2014H, J = 8.4 Hz), 7.03 (s, 1H, Ar\u2014H), 7.33\u20137.65 (m, 12H, Ar\u2014H, CH\u2014triazole), 7.90\u20138.05 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.23\u201316.49, 17.40 (CH3), 55.13 (CHP), 60.35, 63.36\u201363.46 (C5\u2032, CH2), 71.59 (C2\u2032), 75.25 (C3\u2032), 81.22 (C4\u2032), 90.41 (C1\u2032), 112.52, 118.72, 126.05, 128.07\u2013129.94, 133.43\u2013133.87 (phenyl\u2014CH, triazole\u2014CH), 122.80 (C\u2014Cl), 135.79\u2013142.99 (phenyl\u2014C), 147.76 (triazole\u2014C), 165.04\u2013166.06 (CO). ESI\u2010MS (M+H), m/z calcd. for C46H44ClN4O10P: 879.29, found: 880.00; HRMS (M+K): calcd. for C46H44ClN4O10PK: 917.21206, found: 917.21196.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(4\u2010chloro\u20102\u2010methylphenylamino)methyl]phosphonate 4f\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 90%; Rf: 0.45; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.98 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.19 (t, 3H, \u2014CH3, J = 6.9 Hz), 3.61 (m, 1H, \u2014OCH2\u2014), 3.84 (m, 1H, \u2014OCH2\u2014), 4.03 (m, 2H, \u2014OCH2\u2014), 4.45 (m, 1H, H5\u2032), 4.65\u20134.88 (m, 3H, CHP, H5\u2032, H4\u2032), 5.19 (br s, 1H, NH), 6.03 (m, 1H, H3\u2032), 6.19 (m, 1H, H2\u2032), 6.38 (d, 1H, H1\u2032, J = 3.3 Hz), 6.61 (s, 1H, Ar\u2014H), 6.90\u20137.53 (m, 19H, Ar\u2014H, CH\u2014triazole), 7.76\u20137.89 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.33\u201316.51 (CH3), 54.91 (CHP), 56.91, 63.45\u201363.59 (C5\u2032, CH2), 71.59 (C2\u2032), 75.26 (C3\u2032), 81.21 (C4\u2032), 90.41 (C1\u2032), 106.50, 118.20, 118.78, 122.51, 126.34, 127.58\u2013129.88, 133.43\u2013133.86 (phenyl\u2014CH, triazole\u2014CH), 134.78, 136.00, 143.92\u2013144.12 (phenyl\u2014C), 147.84 (triazole\u2014C), 165.03\u2013166.06 (CO). ESI\u2010MS (M+H), m/z calcd. for C49H45N4O10P: 880.88, found: 882.00; HRMS (M+H): calcd. for C49H45N4O10P: 919.25049, found: 919.24998.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(2\u2010naphthalenylamino)methyl]phosphonate 4g\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 78%; Rf: 0.40; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.08 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.21 (t, 3H, \u2014CH3, J = 6.9 Hz), 3.06 (br s, 1H, NH), 3.48 (d, 1H, CHP, J = 23.4 Hz), 3.72 (m, 2H, \u2014CH2\u2014NH\u2014), 3.76\u20134.02 (m, 4H, \u2014OCH2\u2014), 4.55 (m, 1H, H5\u2032), 4.77\u20134.82 (m, 2H, H4\u2032, H5\u2032), 6.06 (m, 1H, H3\u2032), 6.21 (m, 1H, H2\u2032), 6.46 (m, 1H, H1\u2032, J = 3.6 Hz), 7.17\u20137.47 (m, 16H, Ar\u2014H, CH\u2014triazole), 7.60 (d, 2H, Ar\u2014H, J = 7.8 Hz), 7.76\u20137.89 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.32\u201316.48 (CH3), 51.28 (CHP), 62.92\u201363.57 (C5\u2032, CH2), 71.64 (C2\u2032), 75.28 (C3\u2032), 81.26 (C4\u2032), 90.42 (C1\u2032), 118.56, 125.89, 127.18, 128.36\u2013129.89, 133.47\u2013133.88 (phenyl\u2014CH, triazole\u2014CH), 135.50, 139.19 (phenyl\u2014C), 148.01 (triazole\u2014C), 165.07\u2013166.09 (CO). ESI\u2010MS (M+H), m/z calcd. for C46H45N4O10P: 844.84, found: 845.40; HRMS (M+K): calcd. for C46H45N4O10PK: 883.25049, found: 883.24988.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(benzylamino)methyl]phosphonate 4h\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 84%; Rf: 0.50; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.68 (t, 3H, \u2014CH3, J = 6.6 Hz), 0.97 (t, 3H, \u2014CH3, J = 6.9 Hz), 0.99\u20131.32 (m, 23H, \u2014CH3, \u2014CH2\u2014), 2.31 (m, 2H, \u2014CH2\u2014NH\u2014), 3.01 (br s, 1H, NH), 3.67 (m, 1H, \u2014OCH2\u2014), 3.73\u20133.99 (m, 4H, \u2014OCH2\u2014, CHP), 4.42 (m, 1H, H5\u2032), 4.77\u20134.82 (m, 2H, H4\u2032, H5\u2032), 5.97 (m, 1H, H3\u2032), 6.11 (m, 1H, H2\u2032), 6.45 (d, 1H, H1\u2032, J = 4.0 Hz), 7.19\u20137.44 (m, 13H, Ar\u2014H, CH\u2014triazole), 7.77\u20137.89 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 14.50, 16.32\u201316.47 (CH3), 22.50, 27.00, 28.72\u201333.87, 40.21 (CH2), 55.00 (CHP), 63.00\u201363.49 (C5\u2032, CH2), 71.59 (C2\u2032), 75.28 (C3\u2032), 81.31 (C4\u2032), 90.48 (C1\u2032), 119.16, 124.79, 125.71, 126.50, 127.42\u2013133.88 (phenyl\u2014CH, triazole\u2014CH), 135.88\u2013136.76 (phenyl\u2014C), 147.50 (triazole\u2014C), 165.00\u2013166.00 (CO). ESI\u2010MS (M+H), m/z calcd. for C51H63N4O10P: 923.04, found: 924.00.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(dodecylamino)methyl]phosphonate 4i\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 80%; Rf: 0.50; Eluent: ethyl acetate/hexane, 8:2 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.77 (t, 3H, \u2014CH3, J = 6.6 Hz), 1.06\u20131.41 (m, 38H, \u2014CH3, \u2014CH2\u2014), 2.39 (m, 2H, \u2014CH2\u2014NH\u2014), 3.05 (br s, 1H, NH), 3.73 (m, 1H, \u2014OCH2\u2014), 3.84\u20134.01 (m, 4H, \u2014OCH2\u2014, CHP), 4.53 (m, 1H, H5\u2032), 4.80\u20134.91 (m, 2H, H4\u2032, H5\u2032), 6.06 (m, 1H, H3\u2032), 6.21 (m, 1H, H2\u2032), 6.47 (d, 1H, H1\u2032, J = 4.0 Hz), 7.30\u20137.55 (m, 13H, Ar\u2014H, CH\u2014triazole), 7.88\u20138.00 (m, 7H, Ar\u2014H). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 14.10, 16.33\u201316.47 (CH3), 22.67, 27.18, 29.34\u201329.82, 31.91, 48.60 (CH2), 59.50 (CHP), 63.01\u201363.55 (C5\u2032, CH2), 71.64 (C2\u2032), 75.27 (C3\u2032), 81.28 (C4\u2032), 90.40 (C1\u2032), 118.40, 125.76, 128.53\u2013129.89, 133.46\u2013133.86 (phenyl\u2014CH, triazole\u2014CH), 135.00 (phenyl\u2014C), 149.00 (triazole\u2014C), 165.05\u2013166.04 (CO). ESI\u2010MS (M+H), m/z calcd. for C57H75N4O10P: 1007.20, found: 1007.90; HRMS (M+K): calcd. for C57H75N4O10PK: 1045.48524, found: 1045.48309.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(2,3,5\u2010tri\u2010O\u2010benzoyl\u2010\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(octadecylamino)methyl]phosphonate 4j\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "To a solution of 1,2,3\u2010triazole nucleoside analogs 4 (0.45 mmol) in dry methanol (2.5 mL), sodium methoxide (1 equiv.) was added. The reaction mixture was stirred at room temperature until the reaction was complete (30 min). The neutralization was performed with AmberliteIR120 hydrogen form. Afterwards the residue was filtered and evaporated. The crude product was purified by flash silica gel chromatography.",
            "cite_spans": [],
            "section": "General procedure for the synthesis of diethyl [(4\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)(aryl or alkylamino)(phenyl)methyl]phosphonates 5a\u2013j\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 98%; Rf: 0.30; Eluent: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.98\u20131.18 (m, 6H, \u2014CH3), 3.61 (m, 1H, H\u20105\u2032A), 3.69\u20133.86 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 3.93\u20134.02 (m, 4H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032), 4.12 (d, 1H, \u2014OH, J = 5.3 Hz), 4.40 (t, 1H, \u2014OH, J = 5.0 Hz), 4.54 (d, 1H, \u2014OH, J = 5.3 Hz), 4.68 (d, 1H, CHP, J = 24.6 Hz), 4.95 (br s, 1H, NH), 5.93 (d, 1H, H\u20101\u2032, J = 6.3 Hz), 6.51\u20136.58 (m, 3H, Ar\u2014H), 6.98 (t, 2H, Ar\u2014H, J = 7.5 Hz), 7.30 (m, 2H, Ar\u2014H), 7.42 (d, 2H, Ar\u2014H, J = 7.5 Hz), 7.82 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.15\u201316.41 (CH3), 54.55 (CHP), 61.88\u201363.79 (C5\u2032, CH2), 70.87 (C2\u2032), 75.99 (C3\u2032), 85.84 (C4\u2032), 92.88 (C1\u2032), 113.95, 118.60, 120.00, 125.86, 128.36\u2013129.52 (phenyl\u2014CH, triazole\u2014CH), 135.79, 146.11\u2013146.73 (phenyl\u2014C, triazole\u2014C). ESI\u2010MS (M+H), m/z calcd. for C24H31N4O7P: 518.50, found: 520.00; HRMS (M+K): calcd. for C24H31N4O7PK: 557.15619, found: 557.15544.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(phenylamino)methyl]phosphonate 5a\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 99%; Rf: 0.32; Eluent: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.08\u20131.26 (m, 6H, \u2014CH3), 3.57\u20133.61 (m, 1H, H\u20105\u2032A), 3.69\u20133.79 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 3.84\u20134.07 (m, 4H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032), 4.11 (d, 1H, \u2014OH, J = 5.3 Hz), 4.38 (t, 1H, \u2014OH, J = 5.0 Hz), 4.52 (d, 1H, \u2014OH, J = 5.3 Hz), 4.72 (d, 1H, CHP, J = 24.6 Hz), 5.24 (br s, 1H, NH), 6.01 (d, 1H, H\u20101\u2032, J = 6.3 Hz), 6.43 (d, 1H, Ar\u2014H, J = 8.1 Hz), 6.58 (d, 1H, Ar\u2014H, J = 6.3 Hz), 6.93 (t, 1H, Ar\u2014H, J = 7.2 Hz), 7.20 (m, 1H, Ar\u2014H), 7.47 (t, 2H, Ar\u2014H, J = 6.6 Hz), 7.51 (m, 2H, Ar\u2014H), 7.98 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.01\u201316.41 (CH3), 54.50 (CHP), 61.85\u201363.94 (C5\u2032, CH2), 70.90 (C2\u2032), 76.03 (C3\u2032), 85.89 (C4\u2032), 92.95 (C1\u2032), 112.75, 117.63, 118.84, 120.01, 122.39, 125.97, 127.76\u2013128.12, 129.26, 133.73 (phenyl\u2014CH, triazole\u2014CH), 120.09 (C\u2014Cl), 129.73, 135.17, 141.96 (phenyl\u2014C), 146.68 (triazole\u2014C). ESI\u2010MS (M+H), m/z calcd. for C24H30ClN4O7P: 552.94, found: 553.80; HRMS (M+K): calcd. for C24H30ClN4O7PK: 591.11722, found: 591.11690.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(2\u2010chlorophenylamino)methyl]phosphonate 5b\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 98%; Rf: 0.30; Eluent: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.10\u20131.20 (m, 6H, \u2014CH3), 3.59\u20133.62 (m, 1H, H\u20105\u2032A), 3.71\u20133.88 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 3.90\u20134.06 (m, 4H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032), 4.11 (d, 1H, \u2014OH, J = 5.3 Hz), 4.39 (t, 1H, \u2014OH, J = 5.0 Hz), 4.51 (d, 1H, \u2014OH, J = 5.3 Hz), 4.76 (d, 1H, CHP, J = 19.8 Hz), 5.25 (br s, 1H, NH), 5.78 (d, 1H, H\u20101\u2032, J = 6.3 Hz), 6.34 (d, 1H, Ar\u2014H, J = 7.2 Hz), 6.43 (t, 1H, Ar\u2014H, J = 7.3 Hz), 6.91 (t, 1H, Ar\u2014H, J = 7.8 Hz), 7.19 (m, 3H, Ar\u2014H), 7.47 (m, 2H, Ar\u2014H), 7.65 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.23\u201316.46 (CH3), 54.77 (CHP), 61.87\u201364.07 (C5\u2032, CH2), 70.90 (C2\u2032), 76.09 (C3\u2032), 85.95 (C4\u2032), 93.04 (C1\u2032), 110.55 (C\u2014Br), 112.81, 119.36, 119.86, 125.99, 128.17\u2013128.43, 132.52 (phenyl\u2014CH, triazole\u2014CH), 129.74, 135.14, 145.95 (phenyl\u2014C), 146.71 (triazole\u2014C). ESI\u2010MS (M+H), m/z calcd. for C24H30BrN4O7P: 597.40, found: 598.00; HRMS (M+K): calcd. for C24H30BrN4O7PK: 635.06671, found: 635.06660.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(2\u2010bromophenylamino)methyl]phosphonate 5c\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 99%; Rf: 0.33; Eluent: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 1.02\u20131.27 (m, 6H, \u2014CH3), 3.65 (m, 1H, H\u20105\u2032A), 3.68\u20133.79 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 3.84\u20134.14 (m, 4H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032), 4.21 (d, 1H, \u2014OH, J = 5.3 Hz), 4.48 (t, 1H, \u2014OH, J = 5.0 Hz), 4.66 (d, 1H, \u2014OH, J = 5.3 Hz), 4.74 (d, 1H, CHP, J = 25.2 Hz), 5.25 (br s, 1H, NH), 6.04 (d, 1H, H\u20101\u2032, J = 6.2 Hz), 6.49 (d, 2H, Ar\u2014H, J = 8.4 Hz), 7.12 (d, 2H, Ar\u2014H, J = 8.4 Hz), 7.37 (d, 2H, Ar\u2014H, J = 8.0 Hz), 7.53 (d, 2H, Ar\u2014H, J = 7.6 Hz), 8.04 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.15\u201316.41 (CH3), 56.48 (CHP), 61.91\u201363.80 (C5\u2032, CH2), 70.86 (C2\u2032), 75.92 (C3\u2032), 85.75 (C4\u2032), 92.82 (C1\u2032), 110.14 (C\u2014Br), 115.54, 120.14, 125.92, 128.38, 131.87 (phenyl\u2014CH, triazole\u2014CH), 129.63, 135.39, 145.47 (phenyl\u2014C), 146.74 (triazole\u2014C). ESI\u2010MS (M+H), m/z calcd. for C24H30BrN4O7P: 597.40, found: 598.10; HRMS (M+K): calcd. for C24H30BrN4O7PK: 635.06671, found: 635.06616.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(4\u2010bromophenylamino)methyl]phosphonate 5d\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 95%; Rf: 0.35; Eluent: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.78\u20131.18 (m, 6H, \u2014CH3), 3.60 (m, 1H, H\u20105\u2032A), 3.62\u20133.87 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 3.93\u20134.06 (m, 4H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032), 4.11 (d, 1H, \u2014OH, J = 5.3 Hz), 4.39 (t, 1H, \u2014OH, J = 5.0 Hz), 4.55 (d, 1H, \u2014OH, J = 6.2 Hz), 4.63 (d, 1H, CHP, J = 24.6 Hz), 5.29 (br s, 1H, NH), 5.95 (d, 1H, H\u20101\u2032, J = 6.4 Hz), 6.46 (d, 2H, Ar\u2014H, J = 8.0 Hz), 6.66 (d, 2H, Ar\u2014H, J = 8.1 Hz), 7.28 (d, 2H, Ar\u2014H, J = 7.6 Hz), 7.44 (d, 2H, Ar\u2014H, J = 7.5 Hz), 7.93 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.10\u201316.37 (CH3), 55.14 (CHP), 61.88\u201363.75 (C5\u2032, CH2), 70.86 (C2\u2032), 75.96 (C3\u2032), 85.80 (C4\u2032), 92.86 (C1\u2032), 114.89\u2013115.78, 120.07, 125.88, 128.39 (phenyl\u2014CH, triazole\u2014CH), 129.60, 135.65, 142.62 (phenyl\u2014C), 146.75 (triazole\u2014C), 154.67 (C\u2014F). ESI\u2010MS (M+H), m/z calcd. for C24H30FN4O7P: 536.49, found: 538.10; HRMS (M+K): calcd. for C24H30FN4O7PK: 575.14677, found: 575.14637.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(4\u2010fluorophenylamino)methyl]phosphonate 5e\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 98%; Rf: 0.30; Eluent: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.83\u20131.02 (m, 6H, \u2014CH3), 1.96 (s, 3H, Ar\u2014CH3), 3.49 (m, 1H, H\u20105\u2032A), 3.50\u20133.68 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 3.71\u20134.84 (m, 4H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032), 3.94 (d, 1H, \u2014OH, J = 5.0 Hz), 4.12 (t, 1H, \u2014OH, J = 7.0 Hz), 4.21 (d, 1H, \u2014OH, J = 5.0 Hz), 4.36 (br s, 1H, NH), 4.50 (d, 1H, CHP, J = 24.6 Hz), 5.76 (d, 1H, H\u20101\u2032, J = 7.6 Hz), 6.02 (d, 2H, Ar\u2014H, J = 8.5 Hz), 6.60 (d, 2H, Ar\u2014H, J = 7.2 Hz), 6.73 (s, 1H, Ar\u2014H), 7.13 (d, 2H, Ar\u2014H, J = 6.6 Hz), 7.32 (d, 2H, Ar\u2014H, J = 6.3 Hz), 7.77 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.29\u201316.53, 17.45 (CH3), 54.89 (CHP), 62.01\u201363.85 (C5\u2032, CH2), 70.97 (C2\u2032), 76.09 (C3\u2032), 85.93 (C4\u2032), 92.99 (C1\u2032), 112.58, 120.14, 126.07, 126.65, 128.19, 130.10 (phenyl\u2014CH, triazole\u2014CH), 123.00 (C\u2014Cl), 125.01,129.81, 135.52, 142.91 (phenyl\u2014C), 146.83 (triazole\u2014C). ESI\u2010MS (M+H), m/z calcd. for C25H32ClN4O7P: 566.97, found: 568.10; HRMS (M+K): calcd. for C25H32ClN4O7PK: 605.13287, found: 605.13238.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(4\u2010chloro\u20102\u2010methylphenylamino)methyl]phosphonate 5f\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 98%; Rf: 0.35; Eluent: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.99\u20131.38 (m, 6H, \u2014CH3), 3.65 (m, 1H, H\u20105\u2032A), 3.70\u20133.86 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 3.96\u20134.08 (m, 4H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032), 4.18 (d, 1H, \u2014OH, J = 5.4 Hz), 4.46 (t, 1H, \u2014OH, J = 5.3 Hz), 4.61 (d, 1H, \u2014OH, J = 6.0 Hz), 4.90 (d, 1H, CHP, J = 24.0 Hz), 5.35 (br s, 1H, NH), 5.99 (d, 1H, H\u20101\u2032, J = 6.6 Hz), 6.72 (s, 1H, Ar\u2014H), 7.01 (d, 1H, Ar\u2014H, J = 8.1 Hz), 7.10 (t, 1H, Ar\u2014H, J = 6.9 Hz), 7.28 (dd, 1H, Ar\u2014H, J = 7.2, 2.1 Hz), 7.39\u20137.56 (m, 7H, Ar\u2014H), 7.86 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.10\u201316.38 (CH3), 54.46 (CHP), 61.89, 63.54\u201363.84 (C5\u2032, CH2), 70.84 (C2\u2032), 75.89 (C3\u2032), 85.74 (C4\u2032), 92.79 (C1\u2032), 106.27, 118.16, 120.05, 122.52, 125.83\u2013126.39, 127.54, 128.31, 129.07 (phenyl\u2014CH, triazole\u2014CH), 127.86, 134.68, 135.56, 143.88, 144.06 (phenyl\u2014C), 146.69 (triazole\u2014C). ESI\u2010MS (M+H), m/z calcd. for C28H33N4O7P: 568.56, found: 570.20; HRMS (M+K): calcd. for C28H33N4O7PK: 607.17184, found: 607.17152.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(2\u2010naphthalenylamino)methyl]phosphonate 5g\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 95%; Rf: 0.30; Eluent: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.83\u20131.02 (m, 6H, \u2014CH3), 2.57 (br s, 1H, NH), 3.27 (m, 2H, \u2014CH2\u2014NH\u2014), 3.57 (m, 1H, H\u20105\u2032A), 3.60\u20133.71 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 3.73\u20133.83 (m, 4H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032), 3.98 (d, 1H, \u2014OH, J = 5.0 Hz), 4.24 (t, 1H, \u2014OH, J = 4.9 Hz), 4.38 (d, 1H, \u2014OH, J = 6.2 Hz), 4.76 (d, 1H, CHP, J = 24.6 Hz), 5.83 (d, 1H, H\u20101\u2032, J = 6.3 Hz), 6.98\u20137.03 (m, 5H, Ar\u2014H), 7.16 (d, 2H, Ar\u2014H, J = 6.31 Hz), 7.45 (d, 7H, Ar\u2014H, J = 6.3 Hz), 7.94 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 16.28\u201316.47 (CH3), 54.28 (CHP), 56.00, 62.50\u201363.50 (C5\u2032, CH2), 71.00 (C2\u2032), 76.26 (C3\u2032), 84.50 (C4\u2032), 93.22 (C1\u2032), 119.50, 126.03, 127.50, 128.58\u2013130.06 (phenyl\u2014CH, triazole\u2014CH), 135.50, 139.00 (phenyl\u2014C), 147.50 (triazole\u2014C). ESI\u2010MS (M+H), m/z calcd. for C25H33N4O7P: 532.53, found: 534.10; HRMS (M+K): calcd. for C25H33N4O7PK: 571.17184, found: 571.17077.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(benzylamino)methyl]phosphonate 5h\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 96%; Rf: 0.34; Eluant: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.92 (m, 6H, \u2014OCH2CH3, \u2014CH3), 1.15\u20131.67 (m, 23H, \u2014CH2\u2014, \u2014OCH2CH3), 7.60 (br s, 1H, NH), 2.33 (m, 2H, \u2014CH2\u2014NH\u2014), 3.52 (m, 1H, H\u20105\u2032A), 3.83\u20133.91 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 3.99\u20134.20 (m, 5H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032, CHP), 4.31 (d, 1H, \u2014OH, J = 5.0 Hz), 4.63 (t, 1H, \u2014OH, J = 4.9 Hz), 4.91 (d, 1H, \u2014OH, J = 6.1 Hz), 6.12 (d, 1H, H\u20101\u2032, J = 6.4 Hz), 7.28 (d, 2H, Ar\u2014H, J = 8.2 Hz), 7.85 (d, 2H, Ar\u2014H, J = 8.2 Hz), 8.07 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 14.50, 16.00\u201316.50 (CH3), 22.65, 27.05, 29.26\u201340.89 (CH2), 54.50 (CHP), 61.00\u201361.88 (C5\u2032, CH2), 70.85 (C2\u2032), 75.64 (C3\u2032), 86.48 (C4\u2032), 92.80 (C1\u2032), 121.10, 125.44, 128.41 (phenyl\u2014CH, triazole\u2014CH), 133.00\u2013135.00 (phenyl\u2014C), 147.0 (triazole\u2014C). ESI\u2010MS (M+H), m/z calcd. for C30H51N4O7P: 610.72, found: 611.00.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(dodecylamino)methyl]phosphonate 5i\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Yield: 97%; Rf: 0.36; Eluant: CH2Cl2/MeOH, 95:5 v/v; 1H NMR (300 MHz, CDCl3) \u03b4 (ppm): 0.78 (t, 3H, \u2014CH3, J = 6.9 Hz), 1.04\u20131.50 (m, 38H, \u2014CH3, \u2014CH2\u2014), 1.99 (br s, 1H, NH), 2.21 (m, 2H, \u2014CH2\u2014NH\u2014), 3.70 (m, 1H, H\u20105\u2032A), 3.75\u20134.15 (m, 4H, \u2014OCH2\u2014, H\u20105\u2032B, H\u20104\u2032), 4.20\u20134.46 (m, 5H, \u2014OCH2\u2014, H\u20102\u2032,3\u2032, CHP), 4.51 (d, 1H, \u2014OH, J = 5.0 Hz), 4.87 (t, 1H, \u2014OH, J = 5.2 Hz), 5.29 (d, 1H, \u2014OH, J = 5.3 Hz), 5.99 (d, 1H, H1\u2032, J = 4.0 Hz), 7.34 (d, 2H, Ar\u2014H, J = 8.4 Hz), 7.67 (d, 2H, Ar\u2014H, J = 8.4 Hz), 8.12 (s, 1H, CH\u2014triazole). 13C NMR (75 MHz, CDCl3) \u03b4 (ppm): 14.09, 16.00\u201316.26 (CH3), 22.67, 24.78, 27.08, 29.10\u201329.69, 31.91, 33.95 (CH2), 54.50 (CHP), 63.00\u201363.61 (C5\u2032, CH2), 71.50 (C2\u2032), 76.00 (C3\u2032), 86.00 (C4\u2032), 93.00 (C1\u2032), 121.00, 125.44, 128.41 (phenyl\u2014CH, triazole\u2014CH), 133.20\u2013135.10 (phenyl\u2014C), 147.25 (triazole\u2014C). ESI\u2010MS (M+H), m/z calcd. for C36H63N4O7P: 694.88, found: 696.10; HRMS (M+K): calcd. for C36H63N4O7PK: 733.40660, found: 733.40525.",
            "cite_spans": [],
            "section": "Diethyl [(4\u2010(1\u2010(\u03b2\u2010D\u2010ribofuranos\u20101\u2010yl)\u20101,2,3\u2010triazol\u20104\u2010yl)phenyl)(octadecylamino)methyl]phosphonate 5j\n ::: Chemistry ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The compounds were evaluated against the following viruses: herpes simplex virus type 1 (HSV\u20101) strain KOS, thymidine kinase\u2010deficient (TK\u2212) HSV\u20101 KOS strain resistant to ACV (ACVr), herpes simplex virus type 2 (HSV\u20102) strains Lyons and G, varicella\u2010zoster virus (VZV) strain Oka, TK\u2212 VZV strain 07\u22121, human cytomegalovirus (HCMV) strains AD\u2010169 and Davis, vaccinia virus Lederle strain, respiratory syncytial virus (RSV) strain Long, vesicular stomatitis virus (VSV), Coxsackie B4, parainfluenza 3, influenza virus A (subtypes H1N1, H3N2), influenza virus B, Reovirus\u20101, Sindbis, Reovirus\u20101, Punta Toro, human immunodeficiency virus type 1 strain IIIB, and human immunodeficiency virus type 2 strain ROD. The antiviral, other than anti\u2010HIV, assays were based on inhibition of virus\u2010induced cytopathicity or plaque formation in human embryonic lung (HEL) fibroblasts, African green monkey cells (Vero), human epithelial cells (HeLa), or Madin\u2013Darby canine kidney cells. Confluent cell cultures in microtiter 96\u2010well plates were inoculated with 100 CCID50 of virus (1 CCID50 being the virus dose to infect 50% of the cell cultures) or with 20 plaque forming units (PFU) (VZV) in the presence of varying concentrations of the test compounds. Viral cytopathicity or plaque formation was recorded as soon as it reached completion in the control virus\u2010infected cell cultures that were not treated with the test compounds. Antiviral activity was expressed as the EC50 or compound concentration required to reduce virus\u2010induced cytopathogenicity or viral plaque formation by 50%. The methodology of the anti\u2010HIV assays was as follows: human CEM (\u223c3 \u00d7 105 cells/mL) were infected with 100 CCID50 of HIV\u20101(IIIB) or HIV\u20102(ROD)/mL and seeded in 200\u2010\u03bcL\u2010wells of a microtiter plate containing appropriate dilutions of the test compounds. After 4 days of incubation at 37\u00b0C, HIV\u2010induced CEM giant cell formation was examined microscopically.",
            "cite_spans": [],
            "section": "Antiviral activity and cytotoxicity assays ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "Cytotoxicity of the test compounds was expressed as the minimum cytotoxic concentration (MCC) or the compound concentration that caused a microscopically detectable alteration of cell morphology. Alternatively, the cytostatic concentration was calculated as the CC50, or the compound concentration required reducing cell proliferation by 50% relative to the number of cells in the untreated controls.",
            "cite_spans": [],
            "section": "Antiviral activity and cytotoxicity assays ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "\nThis project was supported by Centre National de Recherche Scientifique et Technique project RS/2011/01 (Rabat, Morocco). The authors thank the University of Frankfurt for logistic support and all members of the instrumental laboratory for their help (NMR, Mass analysis). The authors also wish to express their gratitude to Mrs. Leentje Persoons, Mrs. Frieda De Meyer, Mrs. Lies Van den Heurck, and Mrs. Lizette van Berckelaer for excellent technical assistance. The biological part of this work was supported by the KU Leuven (GOA 10/014).",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "\nThe authors have declared no conflicts of interest.",
            "cite_spans": [],
            "section": "",
            "ref_spans": []
        },
        {
            "text": "This paper is dedicated to John A. (Jack) Secrist III (University of Alabama) on the occasion of his retirement, in memory of the fruitful scientific collaboration, and for his large contributions to medicinal chemistry.",
            "cite_spans": [],
            "section": "Dedication",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table 1: Results of protected (4a\u2013j) and deprotected (5a\u2013j) triazolo nucleoside phosphonates. \n",
            "type": "table"
        },
        "TABREF1": {
            "text": "Table 2: Cytotoxicity and antiviral activity of some compounds in HeLa cell cultures. \n",
            "type": "table"
        },
        "TABREF2": {
            "text": "Table 3: Cytotoxicity and antiviral activity of 4h in Vero cell cultures. \n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Scheme 1: Reagents and conditions: (i) R\u2010NH2 (1.2 equiv.), H(O)P(OEt)2 (1.2 equiv.), I2 (0.2 equiv.), MeCN, r.t., 1 h; (ii) TBAF (1 equiv.), THF, r.t., 30 min; (iii) azido\u2010ribose (2.5 equiv.), CuI (0.1 equiv.), Et3N (1.1 equiv.), MWI, 5 min; (iv) MeONa (1 equiv.), MeOH, r.t., 30 min.",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Figure 1: X\u2010ray crystallographic structures of compounds 2e, 2f, 3d, and 3g. Displacement ellipsoids are drawn at the 50% probability level.",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "",
            "authors": [],
            "year": 2009,
            "venue": "Handb. Exp. Pharmacol",
            "volume": "189",
            "issn": "",
            "pages": "53-84",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [],
            "year": 2001,
            "venue": "Curr. Med. Chem. Anti\u2010Cancer Agents",
            "volume": "1",
            "issn": "",
            "pages": "301-312",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF2": {
            "title": "",
            "authors": [],
            "year": 1995,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "5",
            "issn": "",
            "pages": "145-150",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "",
            "authors": [],
            "year": 1991,
            "venue": "Phosphorus Sulfur Silicon Relat. Elem",
            "volume": "63",
            "issn": "",
            "pages": "193-215",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF4": {
            "title": "",
            "authors": [],
            "year": 1986,
            "venue": "J. Med. Chem",
            "volume": "29",
            "issn": "",
            "pages": "29-40",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF5": {
            "title": "",
            "authors": [],
            "year": 2008,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "18",
            "issn": "",
            "pages": "2320-2323",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF6": {
            "title": "",
            "authors": [],
            "year": 1952,
            "venue": "J. Am. Chem. Soc",
            "volume": "74",
            "issn": "",
            "pages": "1528-1531",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF7": {
            "title": "",
            "authors": [],
            "year": 1998,
            "venue": "Russ. Chem. Rev",
            "volume": "67",
            "issn": "",
            "pages": "857-882",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF8": {
            "title": "",
            "authors": [],
            "year": 2012,
            "venue": "Molecules",
            "volume": "17",
            "issn": "",
            "pages": "12821-12835",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF9": {
            "title": "",
            "authors": [],
            "year": 1967,
            "venue": "Chem. Ber",
            "volume": "100",
            "issn": "",
            "pages": "2494-2507",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF10": {
            "title": "",
            "authors": [],
            "year": 2001,
            "venue": "",
            "volume": "",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF11": {
            "title": "",
            "authors": [],
            "year": 2002,
            "venue": "J. Org. Chem",
            "volume": "67",
            "issn": "",
            "pages": "3057-3064",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF12": {
            "title": "",
            "authors": [],
            "year": 2002,
            "venue": "Angew. Chem. Int. Ed",
            "volume": "41",
            "issn": "",
            "pages": "2565-2568",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF13": {
            "title": "",
            "authors": [],
            "year": 1997,
            "venue": "Clin. Microbiol. Rev",
            "volume": "10",
            "issn": "",
            "pages": "674-693",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [],
            "year": 2002,
            "venue": "Nat. Rev. Drug. Discov",
            "volume": "1",
            "issn": "",
            "pages": "13-25",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF15": {
            "title": "",
            "authors": [],
            "year": 1998,
            "venue": "Tetrahedron",
            "volume": "54",
            "issn": "",
            "pages": "3807-3816",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "",
            "authors": [],
            "year": 2002,
            "venue": "Farmaco",
            "volume": "57",
            "issn": "",
            "pages": "27-32",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF17": {
            "title": "",
            "authors": [],
            "year": 2001,
            "venue": "Nucleos. Nucleot. Nucl",
            "volume": "20",
            "issn": "",
            "pages": "1811-1821",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF18": {
            "title": "",
            "authors": [],
            "year": 2003,
            "venue": "Bioorg. Med. Chem",
            "volume": "11",
            "issn": "",
            "pages": "3633-3639",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF19": {
            "title": "",
            "authors": [],
            "year": 2014,
            "venue": "Monatsh. Chem",
            "volume": "145",
            "issn": "",
            "pages": "663-673",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "",
            "authors": [],
            "year": 2010,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "20",
            "issn": "",
            "pages": "7365-7368",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF21": {
            "title": "",
            "authors": [],
            "year": 2009,
            "venue": "J. Org. Chem",
            "volume": "74",
            "issn": "",
            "pages": "4393-4395",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF22": {
            "title": "",
            "authors": [],
            "year": 2010,
            "venue": "J. Iran Chem. Soc",
            "volume": "7",
            "issn": "",
            "pages": "227-236",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF23": {
            "title": "",
            "authors": [],
            "year": 2006,
            "venue": "Org. Biomol. Chem",
            "volume": "4",
            "issn": "",
            "pages": "1663-1666",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF24": {
            "title": "",
            "authors": [],
            "year": 1993,
            "venue": "J. Org. Chem",
            "volume": "58",
            "issn": "",
            "pages": "6614-6619",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF25": {
            "title": "",
            "authors": [],
            "year": 2013,
            "venue": "Acta Crystallogr. C",
            "volume": "69",
            "issn": "",
            "pages": "1157-1163",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF26": {
            "title": "",
            "authors": [],
            "year": 2000,
            "venue": "Carbohydrate Res",
            "volume": "324",
            "issn": "",
            "pages": "149-160",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF27": {
            "title": "",
            "authors": [],
            "year": 2007,
            "venue": "Bioorg. Med. Chem. Lett",
            "volume": "17",
            "issn": "",
            "pages": "6656-6659",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF28": {
            "title": "",
            "authors": [],
            "year": 2001,
            "venue": "Tetrahedron",
            "volume": "57",
            "issn": "",
            "pages": "9225-9283",
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF29": {
            "title": "",
            "authors": [],
            "year": 2009,
            "venue": "Arkivoc",
            "volume": "3",
            "issn": "",
            "pages": "95-114",
            "other_ids": {
                "DOI": []
            }
        }
    }
}